Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

Compare

4.890

+0.030 (0.62%)

At close: Jan 30, 2026, 4:00 PM EST

4.960

+0.070 (1.43%)

After-hours: Jan 30, 2026, 7:52 PM EST

Ironwood Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	140.41	88.56	92.15	656.2	620.13	362.56
Cash & Short-Term Investments	140.41	88.56	92.15	656.2	620.13	362.56
Cash Growth	59.17%	-3.90%	-85.96%	5.82%	71.04%	104.81%
Accounts Receivable	120.37	81.89	129.12	115.46	114.04	122.35
Receivables	120.37	81.89	129.12	115.46	114.04	122.35
Prepaid Expenses	13.07	11.92	12.01	7.72	8.69	9.19
Restricted Cash	-	-	-	1.25	1.25	1.74
Other Current Assets	-	-	-	-	1.12	-
Total Current Assets	273.84	182.37	233.29	780.63	745.23	495.84
Property, Plant & Equipment	13.44	15.52	18.17	20.31	22.93	25.51
Other Intangible Assets	2.25	2.86	3.68	-	-	-
Long-Term Deferred Tax Assets	101.69	144.23	212.32	283.66	333.29	-
Long-Term Deferred Charges	3.2	3.9	2.4	-	-	-
Other Long-Term Assets	1.64	2.02	1.21	15.92	25.48	37.89
Total Assets	396.06	350.91	471.07	1,101	1,127	559.24
Accounts Payable	1.61	2.13	7.83	0.48	0.94	0.66
Accrued Expenses	19.57	26	47.22	17.71	33.29	15.77
Current Portion of Long-Term Debt	199.51	-	199.56	-	116.86	-
Current Portion of Leases	3.24	3.19	3.13	3.07	3.13	3.13
Current Income Taxes Payable	0.66	0.52	1.24	0.66	-	-
Current Unearned Revenue	1.05	2.03	2.62	-	-	-
Other Current Liabilities	16.88	4.98	14.5	3.61	7.49	12.61
Total Current Liabilities	242.5	38.85	276.1	25.53	161.7	32.17
Long-Term Debt	385	583.99	498.31	396.25	337.33	430.26
Long-Term Leases	10.5	12.3	14.54	16.6	18.48	20.32
Long-Term Unearned Revenue	5.5	1.8	-	-	-	-
Other Long-Term Liabilities	16.72	15.31	28.42	9.77	3.5	13.85
Total Liabilities	660.22	652.24	817.37	448.14	521.02	496.6
Common Stock	0.16	0.16	0.16	0.15	0.16	0.16
Additional Paid-In Capital	1,409	1,395	1,355	1,349	1,543	1,529
Retained Earnings	-1,671	-1,698	-1,699	-696.38	-937.61	-1,466
Comprehensive Income & Other	-1.71	0.92	-3.03	-	-	-
Shareholders' Equity	-264.16	-301.34	-346.3	652.38	605.91	62.64
Total Liabilities & Equity	396.06	350.91	471.07	1,101	1,127	559.24
Total Debt	598.24	599.48	715.54	415.92	475.8	453.7
Net Cash (Debt)	-457.83	-510.92	-623.38	240.29	144.33	-91.14
Net Cash Growth	-	-	-	66.49%	-	-
Net Cash Per Share	-2.63	-3.19	-4.01	1.29	0.88	-0.57
Filing Date Shares Outstanding	162.68	161.81	156.53	154.16	159.22	160.96
Total Common Shares Outstanding	162.68	160.21	156.35	154.03	162.04	160.62
Working Capital	31.34	143.52	-42.81	755.1	583.53	463.67
Book Value Per Share	-1.62	-1.88	-2.21	4.24	3.74	0.39
Tangible Book Value	-266.4	-304.2	-349.98	652.38	605.91	62.64
Tangible Book Value Per Share	-1.64	-1.90	-2.24	4.24	3.74	0.39
Machinery	-	3.89	5.42	4.23	4.13	4.71
Leasehold Improvements	-	7.41	7.41	7.41	7.41	7.41

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q